BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Allergy to pollen
,
Hypothalamus
,
Laryngoscope
,
Fenofibrate
,
rs2300478
,
EGFR
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
neuromuscular depolarizing agents
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
CHRM1
CHRNA2
CYP1B1
PPP2CA
PHLDA1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
ENK_UV_RESPONSE_KERATINOCYTE_DN
PUJANA_BRCA1_PCC_NETWORK
PUJANA_CHEK2_PCC_NETWORK
WALLACE_PROSTATE_CANCER_RACE_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Brain tissue after exposure to domoic acid and recovery
Brains from zebrafish after exposure to domoic acid at high and low doses
Drug Matrix In Vivo Toxicogenomic Study - Rat Heart [Codelink]
Drug target sets for approved compounds
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Succinylcholine-triggerred "masseter spasm" may be a variant normal response.
Anesthesiology in the era of drug shortages: use of a succinylcholine infusion for a laparoscopic si…
Rocuronium as muscle relaxant for electroconvulsive therapy in a patient with adult-onset muscular d…
Anesthesia and electroconvulsive therapy: when succinylcholine is contraindicated.
Estimate of the relative risk of succinylcholine for triggering malignant hyperthermia.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals
Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade Via E-learning
Reversal of Moderate or Superficial Neuromuscular Blockade Induced by Cisatracurium
Incidence of Residual Neuromuscular Blockade in Intra-abdominal Surgery: A Prospective, Observationa…
Effect of Magnesium on the Recovery Time of Neuromuscular Blockade With Sugammadex
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ